Non-small cell lung cancer is a slower-growing variant that can be managed through various approaches, such as radiation therapy, surgery, chemotherapy, and targeted therapy. The tyrosine kinase inhibitors (TKIs) resistance of the epidermal growth factor receptor (EGFR) in advanced mutant non-small cell lung cancer (NSCLC) has a therapeutic challenge. #mrmed #mrmedpharmacy #egfrmutations #lungcancer #nsclc #tagrisso80 Know more: https://mrmedin.mystrikingly.com/blog/challenges-and-opportunities-in-overcoming-egfr-tki-resistance-in-nsclc